Page last updated: 2024-10-24

integrin alpha6-beta1 complex

Definition

Target type: cellularcomponent

An integrin complex that comprises one alpha6 subunit and one beta1 subunit. [PMID:12297042]

The integrin alpha6-beta1 complex is a heterodimeric transmembrane receptor that plays a crucial role in cell-cell and cell-extracellular matrix interactions. It is a key player in various cellular processes, including adhesion, migration, signaling, and differentiation. The cellular component of the integrin alpha6-beta1 complex can be described as follows:

**Extracellular Domain:**

* **Alpha6 subunit:** The alpha6 subunit possesses a large extracellular domain that interacts with the laminin-511/521/332 isoforms of the extracellular matrix. It features a globular head region that binds to the laminin-511/521/332 isoforms, a thigh domain, a calf-1 domain, a calf-2 domain, and a beta-propeller domain.
* **Beta1 subunit:** The beta1 subunit also has a substantial extracellular domain that is responsible for interacting with the alpha6 subunit and forming the heterodimer. It contains a beta-propeller domain, a hybrid domain, a linker region, a PSI domain, and a transmembrane domain.

**Transmembrane Domain:**

* **Alpha6 subunit:** The alpha6 subunit has a single transmembrane domain that anchors the protein to the plasma membrane.
* **Beta1 subunit:** The beta1 subunit also has a single transmembrane domain that is responsible for integrating the complex into the cell membrane.

**Cytoplasmic Domain:**

* **Alpha6 subunit:** The cytoplasmic domain of the alpha6 subunit is relatively short and does not directly interact with intracellular signaling pathways.
* **Beta1 subunit:** The cytoplasmic domain of the beta1 subunit is larger and contains several important functional motifs. It interacts with intracellular signaling proteins, such as talin, kindlin, and integrin-linked kinase (ILK), to mediate signal transduction pathways that regulate cell adhesion, migration, and cytoskeletal organization.

**Association with Other Proteins:**

* **Talin:** This protein binds to the beta1 cytoplasmic domain and plays a crucial role in activating the integrin complex, enabling it to bind to the extracellular matrix.
* **Kindlin:** Another protein that binds to the beta1 cytoplasmic domain, kindlin acts in synergy with talin to enhance integrin activation and promote adhesion.
* **Integrin-linked kinase (ILK):** This protein binds to the beta1 cytoplasmic domain and is involved in various signaling pathways, including those associated with cell survival, proliferation, and migration.

**Cellular Localization:**

* The integrin alpha6-beta1 complex is predominantly expressed on the cell surface, particularly in epithelial cells, where it plays a vital role in cell-cell and cell-extracellular matrix interactions.

**Biological Functions:**

* **Cell adhesion:** The integrin alpha6-beta1 complex mediates cell adhesion to the extracellular matrix, particularly to laminin-511/521/332 isoforms.
* **Cell migration:** This complex plays a crucial role in cell migration by providing traction for cells to move and by signaling pathways that control cell motility.
* **Cell signaling:** The integrin alpha6-beta1 complex can initiate intracellular signaling pathways that regulate cell growth, differentiation, and survival.
* **Tissue development:** This complex is essential for normal tissue development and function, particularly in epithelial tissues.

**Clinical Significance:**

* Mutations in the alpha6 or beta1 subunits have been linked to several human diseases, including epidermolysis bullosa, a group of genetic skin disorders characterized by blistering, and various types of cancer.

Overall, the integrin alpha6-beta1 complex is a critical component of the cellular machinery responsible for maintaining cell-cell and cell-extracellular matrix interactions, playing a vital role in a wide range of biological processes and having important implications for human health.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Integrin beta-1An integrin beta-1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P05556]Homo sapiens (human)

Compounds (17)

CompoundDefinitionClassesRoles
haloperidolhaloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
1,3-ditolylguanidine1,3-ditolylguanidine: structure given in first source; a selective ligand for the sigma binding sites in the braintoluenes
tirofibantirofiban : A member of the class of piperidines that is L-tyrosine in which a hydrogen attached to the amino group is replaced by a butylsulfonyl group and in which the hydrogen attached to the phenolic hydroxy group is replaced by a 4-(piperidin-4-yl)butyl group.

Tirofiban: Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME.
L-tyrosine derivative;
piperidines;
sulfonamide
anticoagulant;
fibrin modulating drug;
platelet glycoprotein-IIb/IIIa receptor antagonist
arginyl-glycyl-aspartic acidarginyl-glycyl-aspartic acid: amino acid sequence of basic unit of widespread cellular recognition systemoligopeptide
arginyl-glycyl-aspartyl-serinearginyl-glycyl-aspartyl-serine: corresponds to cell attachment site of fibronectin; located near carboxyl-terminal region of alpha-chain of fibrinogen; inhibits platelet aggregation & fibrinogen binding to activated platelets
glycyl-arginyl-glycyl-aspartyl-serineglycyl-arginyl-glycyl-aspartyl-serine: synthetic peptide from fibronectins; inhibits experimental metastasis of murine melanoma cells
d-arg-gly-asp-trparginyl-glycyl-aspartyl-tryptophan: a synthetic RGD-containing peptide
l 738167L 738167: structure in first source
cilengitideCilengitide: an alphaVbeta3 integrin antagonist that paralyzes cancer cellsoligopeptide
l 734217L 734217: fibrinogen receptor antagonist; structure given in first source
cyclopaminepiperidinesglioma-associated oncogene inhibitor
arginyl-glycyl-aspartyl-phenylalanine
cyclic(arg-gly-asp-d-phe-val)
mk-0429
mocetinostatmocetinostat : A benzamide obtained by formal condensation of the carboxy group of 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an orally active and isotype-selective HDAC inhibitor which exhibits antitumour activity (IC50 = 0.15, 0.29, 1.66 and 0.59 muM for HDAC1, HDAC2, HDAC3 and HDAC11).

mocetinostat: undergoing phase II clinical trials for treatment of cancer
aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
tr 14035N-(2,6-dichlorobenzoyl)-4-(2',6'-bismethoxyphenyl)phenylalanine: TR-14035 is the (L)-isomer; an antagonist of both alpha4beta1 and beta7 integrins; structure in first source
bio 1211BIO 1211: integrin alpha4beta1 inhibitor; structure in first source